Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0001209191-23-056185

Director sold 49,173 shares at an average $0.93 ($45,675)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ENGLEMAN EDGAR Director 2023-11-16 Sale −7,531 $0.96 $7,230 1,989,685 I: show line 1 in the form
ENGLEMAN EDGAR Director 2023-11-17 Sale −8,211 $0.93 $7,636 1,981,474 I: show line 2 in the form
ENGLEMAN EDGAR Director 2023-11-20 Sale −27,465 $0.92 $25,268 1,954,009 I: show line 3 in the form
ENGLEMAN EDGAR Director 2023-11-16 Sale −1,040 $0.96 $998 274,749 I: show line 4 in the form
ENGLEMAN EDGAR Director 2023-11-17 Sale −1,134 $0.93 $1,055 273,615 I: show line 5 in the form
ENGLEMAN EDGAR Director 2023-11-20 Sale −3,792 $0.92 $3,489 269,823 I: show line 6 in the form
Open-market sales · 49,173 sh · avg $0.93 · $45,675
Loading xslF345X05/doc4.xml…